Genmab A/S at Morgan Stanley Global Healthcare Conference Transcript - Thomson StreetEvents

Genmab A/S at Morgan Stanley Global Healthcare Conference Transcript

Genmab A/S at Morgan Stanley Global Healthcare Conference Transcript - Thomson StreetEvents
Genmab A/S at Morgan Stanley Global Healthcare Conference Transcript
Published Sep 09, 2025
11 pages (7083 words) — Published Sep 09, 2025
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of GMAB.CO presentation 9-Sep-25 11:45am GMT

  
Brief Excerpt:

...Absolutely. So over 25-years, you know approved antibody therapeutic science on the market two them we commercialize (inaudible) is the late stage. (inaudible) and multiple Phase III clinical trials add to that (inaudible) also are moving into more and more late-stage clinical cloud. We will actually make sure that they will grow into the future. And of course, we are also trying to look at the external world or opportunities there like we did perform to a buyer and also from our own pipeline. We actually intend to add more (inaudible) though it actually drive sustainable growth for the coming decades....

  
Report Type:

Transcript

Source:
Company:
Genmab A/S
Ticker
GMAB.CO
Time
11:45am GMT
Format:
PDF Adobe Acrobat
Buy Now

Genmab A/S R&D Update and ASH Data Review Transcript – 2025-12-11 – US$ 54.00 – Edited Transcript of GMAB.CO corporate analyst meeting</ 11-Dec-25 4:00pm GMT

Genmab A/S at Citi Global Healthcare Conference Transcript – 2025-12-04 – US$ 54.00 – Edited Transcript of GMAB.CO presentation 4-Dec-25 2:45pm GMT

Genmab A/S Q3 2025 Earnings Call Transcript – 2025-11-06 – US$ 54.00 – Edited Transcript of GMAB.CO earnings conference call or presentation 6-Nov-25 5:00pm GMT

Genmab A/S Q2 2025 Earnings Call Transcript – 2025-08-07 – US$ 54.00 – Edited Transcript of GMAB.CO earnings conference call or presentation 7-Aug-25 4:00pm GMT

Genmab A/S at Goldman Sachs Global Healthcare Conference Transcript – 2025-06-09 – US$ 54.00 – Edited Transcript of GMAB.CO presentation 9-Jun-25 12:00pm GMT

Genmab A/S Post-ASCO R&D Update Transcript – 2025-06-02 – US$ 54.00 – Edited Transcript of GMAB.CO corporate analyst meeting</ 2-Jun-25 9:00pm GMT

Genmab A/S Q1 2025 Earnings Call Transcript – 2025-05-08 – US$ 54.00 – Edited Transcript of GMAB.CO earnings conference call or presentation 8-May-25 4:00pm GMT

Genmab A/S Annual Shareholders Meeting Transcript – 2025-03-12 – US$ 54.00 – Edited Transcript of GMAB.CO shareholder or annual meeting 12-Mar-25 1:00pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Genmab A/S at Morgan Stanley Global Healthcare Conference Transcript" Sep 09, 2025. Alacra Store. Nov 06, 2026. <http://www.alacrastore.com/thomson-streetevents-transcripts/Genmab-A-S-at-Morgan-Stanley-Global-Healthcare-Conference-T16490225>
  
APA:
Thomson StreetEvents. (2025). Genmab A/S at Morgan Stanley Global Healthcare Conference Transcript Sep 09, 2025. New York, NY: Alacra Store. Retrieved Nov 06, 2026 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Genmab-A-S-at-Morgan-Stanley-Global-Healthcare-Conference-T16490225>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.